Tandem Diabetes Care (TNDM) Property, Plant & Equipment (Net) (2013 - 2026)

Tandem Diabetes Care (TNDM) Property, Plant & Equipment (Net) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 12.38 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 3.89 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 7.42 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 4.06 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 1.82 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 1.56 Bn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 3.10 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 6.35 Bn
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 2.55 Bn
10 Tandem Diabetes Care 1.17 Bn 597.96 Mn 136.79 Mn 83.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 83.25 Mn
Mar 31, 2026 83.25 Mn
Dec 31, 2025 83.58 Mn
Dec 31, 2025 83.58 Mn
Sep 30, 2025 77.92 Mn
Sep 30, 2025 77.92 Mn
Jun 30, 2025 77.51 Mn
Jun 30, 2025 77.51 Mn
Mar 31, 2025 79.22 Mn
Mar 31, 2025 79.22 Mn
Dec 31, 2024 78.15 Mn
Dec 31, 2024 78.15 Mn
Sep 30, 2024 81.06 Mn
Sep 30, 2024 81.06 Mn
Jun 30, 2024 78.63 Mn
Jun 30, 2024 78.63 Mn
Mar 31, 2024 77.53 Mn
Mar 31, 2024 77.53 Mn
Dec 31, 2023 76.54 Mn
Dec 31, 2023 76.54 Mn